Categories
- Global News Feed
- Uncategorized
- Alabama Stem Cells
- Alaska Stem Cells
- Arkansas Stem Cells
- Arizona Stem Cells
- California Stem Cells
- Colorado Stem Cells
- Connecticut Stem Cells
- Delaware Stem Cells
- Florida Stem Cells
- Georgia Stem Cells
- Hawaii Stem Cells
- Idaho Stem Cells
- Illinois Stem Cells
- Indiana Stem Cells
- Iowa Stem Cells
- Kansas Stem Cells
- Kentucky Stem Cells
- Louisiana Stem Cells
- Maine Stem Cells
- Maryland Stem Cells
- Massachusetts Stem Cells
- Michigan Stem Cells
- Minnesota Stem Cells
- Mississippi Stem Cells
- Missouri Stem Cells
- Montana Stem Cells
- Nebraska Stem Cells
- New Hampshire Stem Cells
- New Jersey Stem Cells
- New Mexico Stem Cells
- New York Stem Cells
- Nevada Stem Cells
- North Carolina Stem Cells
- North Dakota Stem Cells
- Oklahoma Stem Cells
- Ohio Stem Cells
- Oregon Stem Cells
- Pennsylvania Stem Cells
- Rhode Island Stem Cells
- South Carolina Stem Cells
- South Dakota Stem Cells
- Tennessee Stem Cells
- Texas Stem Cells
- Utah Stem Cells
- Vermont Stem Cells
- Virginia Stem Cells
- Washington Stem Cells
- West Virginia Stem Cells
- Wisconsin Stem Cells
- Wyoming Stem Cells
- Biotechnology
- Cell Medicine
- Cell Therapy
- Diabetes
- Epigenetics
- Gene therapy
- Genetics
- Genetic Engineering
- Genetic medicine
- HCG Diet
- Hormone Replacement Therapy
- Human Genetics
- Integrative Medicine
- Molecular Genetics
- Molecular Medicine
- Nano medicine
- Preventative Medicine
- Regenerative Medicine
- Stem Cells
- Stell Cell Genetics
- Stem Cell Research
- Stem Cell Treatments
- Stem Cell Therapy
- Stem Cell Videos
- Testosterone Replacement Therapy
- Testosterone Shots
- Transhumanism
- Transhumanist
Archives
Recommended Sites
Stem Cell Agency Plan Falls Far Short of Solving IOM Concerns
Posted: January 30, 2013 at 2:18 am
Posted in Stem Cells, Stem Cell Therapy
Comments Off on Stem Cell Agency Plan Falls Far Short of Solving IOM Concerns
Data From SGEN on Cancer Candidate
Posted: January 30, 2013 at 1:44 am
Seattle Genetics, Inc. (SGEN) recently presented interim results from a phase I study which is evaluating ASG-5ME for the treatment of metastatic pancreatic ductal adenocarcinoma (:PDA).
Seattle Genetics is developing ASG-5ME, an antibody-drug conjugate (ADC) which targets the SLC44A4 antigen, for the treatment of solid tumors. The candidate is being developed in collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc. (ALPMY).
The trial is being conducted to evaluate the safety and activity along with identifying the maximum tolerated dose (MTD) of ASG-5ME in patients suffering from metastatic PDA. Approximately 35 patients with metastatic PDA and a median age of 63 were administered doses ranging from 0.3 milligrams per kilogram (mg/kg) to 1.5 mg/kg administered weekly for three of every four weeks. Data from the study, apart from providing preliminary evidence for antitumor activity, revealed that the candidate was well tolerated.
We note that Seattle Genetics is also evaluating ASG-5ME in the prostate and gastric cancer indications. Seattle Genetics focuses on the development and commercialization of monoclonal antibody-based therapies for cancer.
We remind investors that Seattle Genetics leading drug, Adcetris, is currently approved in the US for the treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant (:ASCT) or after failure of at least two prior multi-agent chemotherapy regimens in patients, who are not suitable for ASCT and the treatment of sALCL in treatment-experienced patients. Adcetris is approved in the EU as well.
Seattle Genetics carries a Zacks Rank #3 (Hold). Pharma stocks, which currently appear to be more attractive include Valeant Pharmaceuticals (VRX) and Salix Pharmaceuticals (SLXP). Both companies carry a Zacks Rank #1 (Strong Buy).
Read the Full Research Report on ALPMY
Read the Full Research Report on SGEN
Zacks Investment Research
More here:
Data From SGEN on Cancer Candidate
Posted in Genetics
Comments Off on Data From SGEN on Cancer Candidate
Vichy Expert interview – What is the interest of stem cells ? – Video
Posted: January 29, 2013 at 9:49 pm
Vichy Expert interview - What is the interest of stem cells ?
By: VichyMiddleEast
See the rest here:
Vichy Expert interview - What is the interest of stem cells ? - Video
Posted in Stem Cell Videos
Comments Off on Vichy Expert interview – What is the interest of stem cells ? – Video
Gwyneth Paltrow use stem cells cosmetics 00 – Video
Posted: January 29, 2013 at 9:49 pm
Gwyneth Paltrow use stem cells cosmetics 00
Gwineth Palthrow and Sonya Dakar presenting Apple Stem Cell Cosmetics on Extra TV at CNBC Get yourself the Hollywood Stars facial treatment on http://www.laduchesse.ro and stay in touch with our beauty news on http://www.laduchessecosmetics.com
By: Isabelle d #39;Envie
The rest is here:
Gwyneth Paltrow use stem cells cosmetics 00 - Video
Posted in Stem Cell Videos
Comments Off on Gwyneth Paltrow use stem cells cosmetics 00 – Video
Blood Stem Cells – immune-mediated keratitis – Video
Posted: January 29, 2013 at 9:49 pm
Blood Stem Cells - immune-mediated keratitis
At present many eye pathologies have the alteration of the eye #39;s privileged immune system in common. The eye #39;s privileged immune system has the objective of protecting the eye from infections, minimizing inflammation and activating a process of complex interrelations, making it complicated ,if not impossible, to fully understand . The more we investigate micro-organisms, innate immunity, adaptive immunity, receptors,substances produced by involved cells, etc..., the more this process #39;s evolution appears to be so structured and interconnected that we have to continually revaluate it. Today #39;s treatment for immunomediate illnesses of the eye is the immunosuppression through drugs such as glucocorticoids, cyclosporine A, tacrolimus, doxycycline , etc.... As an alternative we propose immunoregulation using blood stem cells that know the organism and are able to make decisions, acting by orchestrating the healing of the eye behaving like a small pharmaceutical company that produces the right drug at the right time in these complex interrelations. IMMUNE-MEDIATED KERATITIS Immune-mediated keratitis is a non ulcerative corneal disease characterized by some of the following clinical symptoms: vascularization, edema and inflammatory cell response within the cornea and absence of uveal pathology. In the pathological process there may be temporary painful erosions, but normally the pain is minimal with respect to the dramatic symptoms. This is a pathology with unknown causes but ...
By: Marco Polettini
Read this article:
Blood Stem Cells - immune-mediated keratitis - Video
Posted in Stem Cell Videos
Comments Off on Blood Stem Cells – immune-mediated keratitis – Video
Biotech Showcase 2012_ReNeuron – Video
Posted: January 29, 2013 at 9:49 pm
Biotech Showcase 2012_ReNeuron
ReNeuron is a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need. We have used our unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered "off-the-shelf" to any eligible patient without the need for additional drug treatments. Our lead therapeutic candidate is our ReN001 stem cell therapy for the treatment of patients left disabled by the effects of a stroke. This treatment is currently in clinical development. We are also developing stem cell therapies for other conditions such as critical limb ischaemia, a serious and common side effect of diabetes, and blindness-causing diseases of the retina. http://www.reneuron.com View ReNeuron #39;s Alliance for Regenerative Medicine member profile at alliancerm.org
By: AllianceRegenMed
Read more from the original source:
Biotech Showcase 2012_ReNeuron - Video
Posted in Stem Cell Videos
Comments Off on Biotech Showcase 2012_ReNeuron – Video
Dr Xanya Weiss on Signaling Technology and Stem Cells – Video
Posted: January 29, 2013 at 9:49 pm
Dr Xanya Weiss on Signaling Technology and Stem Cells
Impressive Lecture was offered by Dr Xanya Weiss on Signaling Technology and Stem Cells in ICAD medical conference on Anti-aging Medicine
By: Isabelle Devon
Here is the original post:
Dr Xanya Weiss on Signaling Technology and Stem Cells - Video
Posted in Stem Cell Videos
Comments Off on Dr Xanya Weiss on Signaling Technology and Stem Cells – Video
Stem Cell Lecture – Video
Posted: January 29, 2013 at 9:49 pm
Stem Cell Lecture
Honors lecture over stem cells and cell differentiation. More like a guide through some cool links than a lecture.
By: MrsShawBiology
The rest is here:
Stem Cell Lecture - Video
Posted in Stem Cell Videos
Comments Off on Stem Cell Lecture – Video
A cardiomyocyte derived from induced pluripotent stem cells.ogv – Video
Posted: January 29, 2013 at 9:49 pm
A cardiomyocyte derived from induced pluripotent stem cells.ogv
Short clip showing a cardiomyocyte (heart muscle cell) derived from induced pluripotent stemcells (iPSCs). Visit http://www.stemcellsfreak.com for more info on iPSCs
By: Nikos Korompos
Read the original:
A cardiomyocyte derived from induced pluripotent stem cells.ogv - Video
Posted in Stem Cell Videos
Comments Off on A cardiomyocyte derived from induced pluripotent stem cells.ogv – Video
Mesenchymal stem cells – Video
Posted: January 29, 2013 at 9:49 pm
Mesenchymal stem cells
Just some mesenchymal stem cells, check out http://www.stemcellsfreak.com for more information about them
By: Nikos Korompos
Posted in Stem Cell Videos
Comments Off on Mesenchymal stem cells – Video
